Linden Thomson & Cinney Zhang Portfolio Managers, Equities, AXA IM
April 8, 2022

Why biotech’s history of innovation offers exciting opportunities for investors

The innovation and growth witnessed in the biotech sector over the past two decades have been extraordinary. Together they have created a spate of exciting potential investment opportunities – and we expect the industry’s strong growth prospects to continue into 2022 and beyond.
Data in Health
7 minutes